Carbosin 50 mg inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

carbosin 50 mg inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - carboplatin 10 mg/ml - concentrate for solution for infusion - 50 mg - carboplatin 10 mg/ml - carboplatin

Carbosin 150 mg inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

carbosin 150 mg inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - carboplatin 10 mg/ml - concentrate for solution for infusion - 150 mg - carboplatin 10 mg/ml - carboplatin

Carbosin 600 mg inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

carbosin 600 mg inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - carboplatin 10 mg/ml - concentrate for solution for infusion - 600 mg - carboplatin 10 mg/ml - carboplatin

CARBOSIN 150 Zimbabwe - English - Medicines Control Authority

carbosin 150

pharmachemie (pty) ltd - carboplatin - solution - 10mg

CARBOSIN 500 Zimbabwe - English - Medicines Control Authority

carbosin 500

pharmachemie (pty) ltd - carboplatin - solution - 10mg

Carbosin 150 Namibia - English - Namibia Medicines Regulatory Council

carbosin 150

pharmachemie (pty) ltd - carboplatin - injection - each 1ml solution contains carboplatin 10mg; 150mg vial

Carbosin 450 Namibia - English - Namibia Medicines Regulatory Council

carbosin 450

pharmachemie (pty) ltd - carboplatin - injection - each 1ml solution contains carboplatin 10mg; 450mg vial

Carbosinol Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

carbosinol

inqpharm group sdn. bhd. - phaseolus vulgaris -

Itrazole New Zealand - English - Medsafe (Medicines Safety Authority)

itrazole

viatris limited - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: capsugel red g60csa00150 colloidal silicon dioxide ethanol gelatin hypromellose iron oxide red methylene chloride opacode white s-1-7078 purified water sorbitan stearate sugar spheres titanium dioxide - itraconazole capsules are indicated for the treatment of: · vulvovaginal candidiasis. · pityriasis versicolor, · dermatomycosis - including highly keratinised regions as in plantar tinea pedis and palmer tinea manus, · fungal keratitis, · oral candidiasis, · onychomycosis caused by dermatophytes and/or yeasts. · systemic mycoses, only in the following fungal infections: - systemic aspergillosis - histoplasmosis, - histoplasmosis, maintenance therapy only in aids patients - sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous) - paraconccidioidomycosis, - chromomycosis, - blastomycosis

Sporanox New Zealand - English - Medsafe (Medicines Safety Authority)

sporanox

janssen-cilag (new zealand) ltd - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: erythrosine gelatin   hypromellose indigo carmine macrogol 20000 sugar spheres titanium dioxide - sporanox capsules are indicated for the following conditions: - treatment of vulvovaginal candidiasis. - treatment of pityriasis versicolor. - treatment of dermatomycosis – including highly keratinised regions as in plantar tinea pedis and palmer tinea manus. - treatment of fungal keratitis. - treatment of oral candidiasis. - treatment of onychomycosis caused by dermatophytes and/or yeasts. - systemic mycoses, only in the following fungal infections: o treatment of systemic aspergillosis and candidiasis, o treatment of histoplasmosis, o histoplasmosis, maintenance therapy only in aids patients. o treatment of sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous), o treatment of paracoccidioidomycosis, o treatment of chromomycosis, o treatment of blastomycosis.